Israeli Prime Minister Netanyahu Reveals Successful Treatment for Early-Stage Prostate Cancer

Israeli Prime Minister Benjamin Netanyahu disclosed Friday that he recently underwent successful treatment for early-stage prostate cancer, revealing he had deliberately delayed releasing his annual medical report by two months due to strategic concerns related to the ongoing Middle East conflict.

Netanyahu, 74, made the announcement on his official X (formerly Twitter) account, reassuring the public about his health. “I am healthy and in excellent physical condition,” he wrote, describing the prostate issue as “minor” and “completely treated.”

The prime minister explained that the cancer was discovered during routine follow-up care after he had undergone surgery for an enlarged benign prostate more than a year ago. During a recent monitoring session, doctors identified “a tiny spot of less than a centimeter in the prostate,” which subsequent examination confirmed as “a very early stage of a malignant tumor, with no spread or metastases whatsoever.”

Netanyahu revealed his decision-making process regarding treatment options, noting that his medical team presented him with two choices: ongoing monitoring, a common approach for early-stage prostate cancer, or targeted treatment to eliminate the cancerous cells entirely. He opted for the latter.

“I went to a few short treatments, read a book, and continued working. The spot disappeared completely,” Netanyahu stated, expressing gratitude to the doctors and medical teams at Jerusalem’s Hadassah Hospital who oversaw his care.

The timing of this health disclosure appears carefully calculated. Netanyahu specifically mentioned that he delayed releasing information about his condition to prevent Iran from exploiting it through “false propaganda” against Israel during the current regional conflict, which has now entered its eighth month.

Prostate cancer is one of the most common cancers affecting men, particularly those over 50. The prostate is a small walnut-shaped gland located just below the bladder that produces seminal fluid. When detected early, as in Netanyahu’s case, prostate cancer has excellent treatment outcomes, with survival rates exceeding 95 percent for localized disease.

Netanyahu’s announcement comes during a period of heightened tension in the Middle East. The prime minister has been leading Israel through a complex military operation that began in October 2023 following attacks on Israeli territory. The conflict has drawn international attention and criticism regarding civilian casualties and humanitarian concerns in affected areas.

The prime minister concluded his health announcement with a message of solidarity for those affected by the ongoing conflict, stating, “I pray for the recovery of those wounded in the ongoing war.”

Netanyahu’s health has occasionally been a matter of public interest during his long political career, which has included multiple terms as Israel’s prime minister spanning several decades. At 74, he is the longest-serving prime minister in Israel’s history, having held the position for over 15 years across different periods.

Medical disclosures by world leaders often attract significant attention, not only for their personal implications but also because of potential impacts on governance and political stability. In Netanyahu’s case, the apparently successful treatment and his continued work throughout suggest minimal disruption to his leadership duties.

Health experts note that advancements in prostate cancer treatment have significantly improved outcomes in recent decades, with targeted therapies allowing for more precise intervention with fewer side effects than traditional approaches.

The prime minister’s office has not indicated whether any follow-up treatments will be necessary, though regular monitoring is standard protocol following cancer treatment.